-
Mashup Score: 7Fuzuloparib prolongs PFS in HER2- metastatic breast cancer - 2 hour(s) ago
A benefit was observed in women with germline BRCA1/2 mutations when treated with the PARP inhibitor alone or in combination with apatinib
Source: dailyreporter.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 26ESMO Virtual Journal Club: May 2024 - 1 day(s) ago
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet-
Keep up to date with the latest, practice-changing publications & join the discussion with key opinion leaders in the new #ESMOVirtualJournalClub. Check out the programme & register with yr ESMO membership: https://t.co/MbTXIZigki @E_de_Azambuja @BenjaminBesseMD @giannatempopatr https://t.co/RhzLPQn5Lo
-
-
Mashup Score: 14ESMO Virtual Plenary with AACR Expert Commentary: May 2024 - 1 day(s) ago
The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology.
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet-
#ESMOVirtualPlenary: And straight after the first abstract session tomorrow (9/5), remain connected to discover more promising results on #GIST. 📢 A randomised study of 6 vs 3 years of adjuvant imatinib in pts w/ localised GIST at high risk of relapse. https://t.co/ZhCjVdWsVW… https://t.co/73MTBYvk7k https://t.co/OEkF6OhLE9
-
-
Mashup Score: 21ESMO Academy 2024 - 2 day(s) ago
The ESMO Academy continues to offer delegates a comprehensive, thorough update on the key topics in medical oncology
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 25ESMO Congress 2024: Abstracts - 3 day(s) ago
The abstract submission system is now open
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 21ESMO Congress 2024: Abstracts - 3 day(s) ago
The abstract submission system is now open
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6
Real World Data and Digital Oncology – Digital Health as Cancer Care Facilitator: the Power of a Standardised European Health Record 2024Chairs: Anna Pellat, Carola SchulzSpeakers: Maria Alice Borinelli-Franzoi, DaniĂ«lle Seinstra, Henrique Martins
Source: oncologypro.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 23Education Library | OncologyPRO - 6 day(s) ago
OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts,
Source: oncologypro.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet-
#ESMOBooks authors & readers @ana_bosch79, @LDobovisek, @daniela_oaks, shed light on their motivations for contributing to & reading ESMO's range of educational books. Get practical, first-hand advice in concise, reader-friendly formats👉https://t.co/BNcZXzFUq0 @bozovicspa… https://t.co/vll8waAtRW https://t.co/lobwscrEYi
-
-
Mashup Score: 7Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive - 7 day(s) ago
Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20ESMO Congress 2024: Patient Travel Grant Programme - 7 day(s) ago
Application deadline: 31 May 2024 (12:00 CEST)
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet-
📢Patient advocate travel grant programme now open to help attend #ESMO24 in Barcelona. 📍Free registration to the ESMO Congress 2024 📍Travel & accommodation subsidy of a maximum of 1,000 EUR ⏲️Deadline to apply: 27 May More here 🔗 https://t.co/HtjPceBJEp @TanjaSpanic @BairdAM https://t.co/lLOyVKLh1k
-
#ESMOVirtualPlenary: A progression-free survival benefit was observed in women with germline BRCA1/2 mutations when treated with the #PARPi alone or in combination w/ apatinib. @E_de_Azambuja comments the results on the #ESMODailyReporter 👉https://t.co/6rs5aOL1Af #mbc https://t.co/dIsb4wyblr